Menu
Joint Clinical Trials Office

You are here

Home
An Adaptive, Open-Label, Dose-Finding, Phase 1/2 Study Investigating the Safety, Pharmacokinetics, and Clinical Activity of PRN1008, an Oral BTK Inhibitor, in Patients with Relapsed Immune Thrombocytopenic Purpura
Study Status:
Open to Enrollment
Primary Investigator:
Date: April 25, 2019
Brain Function, Emotions, and Behavior in Healthy Older Adults
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 16, 2019
Positive Valence System Function and Reward Exposure Therapy for Late-Life Depression
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 16, 2019
Efficacy of Biomarker-Guided rTMS for Treatment Resistant Depression
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 16, 2019
A POC Clinical Trial for a First-in-Class Vasopressin 1a Receptor Antagonist
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 19, 2019
A Non-Inferiority Randomized Controlled Clinical Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Consequent to Military Sexual Trauma (MST) in Male and Female Military Personnel and Veterans
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 19, 2019
A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients with Chronic Lymphocytic Leukemia (CLL)
Study Status:
Open to Enrollment
Primary Investigator:
Date: August 6, 2019
Assessment of Physiological Reactions Associated with Post-traumatic Stress Disorder Due to Military Sexual Trauma in Female Service Members
Study Status:
Open to Enrollment
Primary Investigator:
Date: August 9, 2019
Problem Adaptation Therapy for Mild Cognitive Impairment and Depression
Study Status:
Open to Enrollment
Primary Investigator:
Date: August 9, 2019
Relief: A Behavioral Intervention for Depression and Chronic Pain in Primary Care
Study Status:
Open to Enrollment
Primary Investigator:
Date: October 3, 2019